products overview Lantheus provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Our products can help healthcare professionals optimize patient management and outcomes.

Cardiologists, nuclear physicians, internal medicine physicians, nurses, technologists and sonographers working in a variety of clinical settings use our products in echocardiography and nuclear imaging.

Lantheus has a portfolio of 9 products – primary products include DEFINITY®, TechneLite®, Xenon, Cardiolite® and NEUROLITE®.




  • DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension
Nuclear Medicine

  • TechneLite® (Technetium Tc 99m Generator)
  • Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)
  • NEUROLITE® (Kit for the Preparation of Technetium Tc 99m Bicisate for Injection)
  • Xenon-133 (Xenon Xe 133 Gas)
  • QUADRAMET® (Samarium SM 153 Lexidronam Injection)
  • Thallium-201 (Thallous Chloride Tl 201 Injection)
  • Gallium-67 (Gallium Citrate Ga 67 Injection)


For patent information relating to our products, click here.